D9132.PDF

Rev. sci. tech. Off. int. Epiz., 16 (1), 215-225
Disease risks to animal health from artificial
insemination with bovine semen
M.D. Eaglesome & M.M. Garcia
Agriculture and Agri-Food Canada, Animal Diseases Research Institute, 3851 Fallowfield Road, P.O. Box 11300,
Station H, Nepean, Ontario K2H 8P9, Canada
Summary
Two of the major goals of artificial insemination of domesticated animals are to
achieve continuous genetic improvement and to prevent or eliminate venereal
disease. In comparison with natural service, fewer males are needed to artificially
inseminate the same number of females and to produce the same number of
offspring. However, there are risks associated with artificial insemination, which
has the potential to disseminate genetic defects and also to spread infectious
disease nationally and internationally. This paper focuses on the risks of six
specific diseases which are transmitted in bull semen and outlines the
appropriate measures to prevent these risks.
Keywords
Animal diseases - Artificial insemination - Bovines - Genital disease - Risk - Semen.
Introduction
The regular testing of semen donors under official veterinary
supervision has been adopted by governments world-wide as
a means of avoiding the spread of pathogens and reducing
excessive contamination of semen by ubiquitous bacteria.
National standards for semen production and distribution are
usually based on regulatory programmes to ensure that
diseases of importance are identified and appropriate tests are
applied to all sires entering and residing in artificial
insemination (AI) centres. These programmes take into
account the national health status as well as the health status
of the herds and flocks of the semen donors. In interpreting
health status, prime considerations include the sensitivity and
specificity of tests, particularly when they are applied to
individual animals, and the risk of latent infections. Testing
programmes need to be continually improved and updated as
new information on the epidemiology, pathogenesis and
control of traditional diseases becomes available. As hew'
infectious diseases emerge, these additional challenges and
risks must also be met ( 9 2 ) . At the international level,
guidelines are published by the Office International des
Epizooties (OIE) to enable the health of animals in AI centres
to be maintained and to facilitate the global distribution of
semen which is free of specific pathogenic organisms (62).
The aims of this paper are as follows:
a) to provide information on some infectious agents known
to be transmitted in bull semen
b) to discuss risk management methods which will help to
control or prevent disease transmission through semen.
Infectious bovine
rhinotracheitis/infectious
pustular vulvovaginitis
Bovine herpesvirus-1 (BHV-1), also called infectious bovine
rhinotracheitis/infectious pustular vulvovaginitis virus, is a
member of the subfamily Alphaherpesvirinae
and is one of the
most common viral pathogens found in bovine semen.
Reproductive disorders caused by BHV-1 include infectious
pustular vulvovaginitis, endometritis, salpingitis, shortened
oestrus cycles and abortions in susceptible female cattle and
balanoposthitis in susceptible bulls. In BHV-1 infection of the
genital tract of the bull, the virus replicates in the mucosae of
the prepuce, penis and distal part of the urethra, and semen is
most likely to be contaminated during ejaculation by virus
shedding from infected mucosae.
Disease risk
Infections with BHV-1 strains, including attenuated live
vaccine strains, have the ability to remain latent in clinically
normal animals ( 6 5 ) . Following reactivation, the virus is
excreted in respiratory and ocular secretions, or in semen, and
216
in the latter case excretion can be with or without a serum
antibody response ( 9 5 ) . BHV-1 causes economically
important genital, respiratory and neurological diseases in
cattle populations world-wide. Infected animals may be
immunosuppressed and thus be more susceptible to
secondary bacterial infections. BHV-1 infection of the male
genital tract can result in mild or severe clinical signs of
balanoposthitis or can be clinically inapparent (1). Bulls play
an important role in the dissemination of the disease because
the virus is excreted in semen both during the acute phase of
infection and also following the establishment of latent
infection (94).
When assessing the risk of semen containing BHV-1, it is
important to recognise that clinical signs of the disease may
not always be observed in outbreaks of BHV-1 infection in
bulls ( 9 5 ) , and that neither the presence of serum neutralising
(SN) antibodies nor vaccination may completely prevent
shedding of virus in semen. BHV-1 has been detected in
semen from infected AI bulls which showed no signs of
balanoposthitis, rhinotracheitis or generalised disease (28). In
some instances, semen may b e contaminated by a primary
local infection of the prepuce before production of
neutralising antibodies has occurred (103). Moreover,
animals latently infected with BHV-1 may have very low
antibody titres or be seronegative, especially if they have not
been stressed and virus reactivation has not taken place for a
long period of time ( 2 9 ) . In addition, primary genital tract
infection may induce very low antibody responses or even
none at all (94). Studies in North America have shown that
semen from BHV-1 seropositive bulls can be free of virus for
periods of several years when bulls are appropriately managed
in a low-stress environment (57).
Diagnosis and control
Methods of BHV-1 detection currently used by diagnostic
veterinary laboratories include virus isolation, examination of
tissues by the fluorescent antibody (FA) technique and
serological testing (SN test or enzyme-linked immunosorbent
assay [ELISA]). Another method is the 'Cornell semen test', in
which pooled samples of semen are inoculated into
susceptible calves or sheep which are then monitored for
neutralising antibodies to BHV-1 (76). The traditional method
for detection of BHV-1 in bovine semen is virus isolation and
identification in cultures of cells of bovine origin ( 8 6 ) .
Dilution of the semen (1:20 to 1:128), prior to its inoculation
onto cell culture, decreases its cytotoxicity (17, 100, 1 0 4 ) .
Molecular-based techniques are also being developed and
used to detect the virus (97, 103). For example, polymerase
chain reaction (PCR) assays can identify BHV-1 contaminated
semen within one day (103). However, PCR is not yet applied
routinely, even in well-equipped laboratories.
It is preferable to use only seronegative bulls in AI centres and
bulls should be bled for further serological testing 21 days
after the semen has been collected, as recommended by the
OIE ( 6 2 ) . To limit the risks of disease transmission when
Rev. sci tech. Off. int. Epiz., 16(1)
semen is collected from bulls of unknown or positive
serological status, at least two straws per semen batch should
be assayed for virus ( 9 4 ) , because semen is diluted before
being frozen and not all straws will necessarily contain virus.
Assay of blood for gamma-interferon, a measure of cellular
immunity, can be used to discriminate between BHV-1
non-infected (or vaccinated) and infected animals, as well as
to distinguish serologically positive infected bulls from those
with maternal antibodies ( 4 2 ) . Vaccination can be used to
control BHV-1 infection in bulls in AI centres, but is not
generally used at present (95).
Bovine virus diarrhoea
Bovine virus diarrhoea (BVD) virus, a ribonucleic acid (RNA)
virus, has two main types characterised by non-cytopathic
(NCP) or cytopathic (CP) effects on cultured cells. They are
indistinguishable serologically. The NCP biotype may infect
the foetus and establish a persistent infection (PI) which
continues into post-natal life. A high proportion of adult cattle
world-wide have antibody to BVD virus (BVDV), although
most infections in adults are subclinical.
Disease risk
Infection with NCP biotypes causes congenital and enteric
diseases as well as predisposing infections with other
pathogens (e.g. BHV-1, Pasteurella or Salmonella spp.). In the
latter instance, there may be increased disease severity
compared to the disease caused by either agent alone, and this
has been attributed to the immunosuppressive effect of BVDV.
Some NCP biotypes of BVDV have caused haemorrhagic
disease in cattle with a high mortality rate (11) and, in North
America, virulent NCP strains have caused severe diarrhoea
and death in adult cattle and veal calves with clinical signs
similar to those of mucosal disease ( 3 0 ) . The CP biotypes
cause mucosal disease, which occurs only in PI animals. The
CP virus appears to arise by mutation from the NCP virus
within PI animals (59).
BVDV is excreted in bull semen during acute, transient
infection and is also present in the semen of PI bulls ( 5 1 , 52,
66). The virus is transmitted in the semen of such bulls during
natural or artificial breeding ( 5 6 ) , and causes reproductive
losses in females (55, 9 9 ) .
Diagnosis and control
Antibodies to BVDV may be detected by complement fixation
(CF), indirect FA and SN tests (71). In addition, a number of
ELISAs of high serological sensitivity and group specificity
have been described ( 1 , 2 2 ) . Tests to detect BVDV include
virus isolation (1), antigen capture ELISAs (79), and reverse
transcription-PCR assays (68).
It is important that PI bulls are prevented from entering AI
centres. The best method for identifying PI bulls is by
virological examination of two blood samples collected four
217
Rev. sci tech. Off. int. Epiz.,16(1)
weeks apart. As homologous maternal antibody may interfere
with detection of the virus ( 7 1 ) , calves aged less than six
months should be treated as if of unknown status and kept
separate from others. It should be noted that PI bulls can
seroconvert following superinfection or after vaccination with
a virus antigenically dissimilar to the persistent virus ( 3 0 ) .
Although there is some concern that live attenuated vaccines
may be immunosuppressive and potentiate the effect of other
pathogens (1), the emergence of virulent NCP strains, and the
severe losses that they can cause, make it a prudent strategy to
vaccinate bulls (30).
Bovine brucellosis
Bovine brucellosis is a bacterial disease caused mainly by
Brucella abortus. In cattle, the disease is characterised by
abortion and is often associated with retained placenta,
metritis and a subsequent period of infertility. Brucellosis
affects approximately 5% of livestock world-wide and
continues to increase. It is also an important zoonosis.
Disease risk
Brucella abortus infection in bulls may involve the testis and
epididymis, and also the seminal vesicle and ampulla. Infected
bulls may be serologically positive or negative ( 7 0 ) . The
shedding of B. abortus in the semen of bulls has been reported
and this may pose a risk of disease transmission by AI (8). In a
recent study, following the experimental inoculation of
mature bulls, B. abortus strain 19 was constantly present in
semen, and this was accompanied by a specific antibody
response ( 2 0 ) . However, there was no overt increase in
seminal immunoglobulin (Ig) concentration and no definite
conclusions could be made concerning the protective role of
seminal antibodies in limiting spread of infection at service.
Diagnosis and control
Serological tests are applied routinely to monitor for
brucellosis. A major breakthrough was the elucidation of the
structure of the O-chain of the smooth lipopolysaccharide
(LPS) of B. abortus ( 2 1 ) . Indirect and competitive ELISA
formats have been developed and evaluated in several
countries. The ELISA based on use of the O-LPS has been
shown to be capable of discriminating between vaccinated
animals and non-vaccinated, infected animals (61).
Laboratory tests include isolation or demonstration of the
organism in tissues or fluids, and serological tests and
agglutination tests on milk or seminal plasma, as described in
a World Health Organisation (WHO) monograph ( 4 ) . A
colony blot ELISA exploits the use of monoclonal antibodies
to smooth Brucella O-chain to detect Brucella colonies on agar
media even in the presence of contaminants. A specific and
sensitive PCR assay has also been developed ( 3 7 ) .
Deoxyribonucleic acid (DNA) amplification using six
B. abortus gene sequences was found to be highly specific and
sensitive but did not differentiate between the different
Brucella species (27).
Some authorities in Brucella-face countries consider that the
serum agglutination test is sufficiently sensitive for health
certification of Al bulls ( 6 9 ) , although more sensitive tests are
available ( 3 8 , 9 3 ) . Reports of bulls shedding B. abortus in
semen while their serum agglutination titres were low or
negative (6) indicate the benefits of testing semen for the
presence of the organism, or testing seminal plasma for
agglutinins, particularly in areas of high risk. Live strain 19
vaccine and the killed 4 5 / 2 0 vaccine have both played an
important role in the control of brucellosis. However, strain
19 may produce permanent infections in bulls similar to those
of natural disease (60). New vaccines such as RB51, which is
an avirulent rough mutant lacking an O-chain, can induce a
protective cell-mediated immune response without an
accompanying seroconversion ( 7 7 ) , but the value of these
vaccines in the field remains to be tested.
Leptospirosis
Leptospirosis, an important zoonotic disease caused by
parasitic spirochaetes, is endemic in animal populations
world-wide (5). Genetic studies have revealed heterogeneity
among leptospires, and L. interrogans (i.e. the parasitic form)
is now subdivided into seven genospecies (72). There are also
approximately 2 0 0 serovars of parasitic leptospires (102).
Serovar hardjo, the predominant serovar in most cattle
populations ( 1 0 ) , has been divided into two genotypes:
hardjo-prajitno
and hardjo-bovis ( 8 9 ) .
Disease risk
Clinically, bovine leptospirosis can be acute (septicaemia,
hepatitis, nephritis), subacute (nephritis, agalactia), chronic
(abortion, stillbirth, infertility) or, in its most common form,
asymptomatic. Serovar hardjo has been recovered from the
kidney, seminal vesicle, epididymis and testis of naturally
infected bulls (36). Leptospira spp. have also been recovered
from the semen of naturally ( 4 8 ) and experimentally ( 8 4 )
infected bulls, and seminal transmission has been reported
(83).
Diagnosis and control
The reference laboratory test for serological diagnosis of
leptospirosis in cattle is the microscopic agglutination (MA)
test (25). There are also immunoenzyme assays for detection
of leptospiral antibodies and antigens ( 8 8 ) but these, like the
MA test, cannot distinguish between titres resulting from
natural infection and those from vaccinal titres ( 9 1 ) .
Difficulties have been reported in isolating leptospires from
experimentally infected semen, even when antibiotics were
absent from the semen diluent ( 6 9 ) , However, molecular
218
Rev. sci tech. Off. int. Epiz., 16 (1)
probes for leptospira detection and identification have been
described ( 3 1 , 8 5 ) and one PCR used for L. serjoe in non-sterile
urine detected as few as 5-10 leptospires per ml (41 ).
Leptospires survive in extended unfrozen bovine semen,
either with or without antibiotics ( 1 8 ) , and also in frozen
semen without antibiotics ( 7 4 ) . Treatment of bulls with
25 mg of dihydrostreptomycin (DHS) per k g body weight
has been approved intemationally (62) to stabilise low
antibody titres and to prevent shedding of leptospira, but the
efficacy of such treatment is questionable ( 3 5 ) . DHS has,
furthermore, been withdrawn in some countries which means
that other antibiotic treatments (3) will require certification.
As the currently available serological tests cannot differentiate
vaccinal from infectious litres, vaccination of bulls in AI
centres is not usually appropriate.
- 1
Bovine genital
campylobacteriosis
Venereal campylobacteriosis, a widespread bacterial disease
associated with both bovine infertility and abortion, is caused
by Campylobacter (Vibrio) fetus, particularly the subspecies
venerealis. C. fetus infection in cattle has decreased in regions
where AI and vaccination are practised, yet the disease
continues to be an important pathogen causing reproductive
problems in many countries (2, 9 8 ) .
Disease risk
In bulls, infection is not accompanied by either pathological
lesions or modifications in the characteristics of the semen
(23). The incidence of infection is higher among bulls over
five years of age, and this may be attributed to the deeper
epithelial crypts in the prepuce and penis of older bulls which
allow the pathogen to survive and grow more readily. C. fetus
is transmitted to female cattle at natural or artificial service
and causes vaginitis, cervicitis, endometritis and salpingitis.
Infertility can last at least ten months. Persistence of C. fetus
infection in the bovine genital tract may be due to successive
(or intermittent) changes in superficial antigens of the
organism (26). Occurrence of these antigenic shifts in vivo is
associated with genomic rearrangement of the sapA gene
homologs (40).
Diagnosis
Preputial scrapings and semen from bulls are the usual
specimens taken for laboratory tests. Infected bulls produce
IgA in their preputial secretions but the titres tend to be so low
that they are indistinguishable from those present before
infection (101). Recovery of C. fetus from field cases can be
difficult, which may be due to the microaerobic requirements
of the organisms. Special transport media have been
developed to maintain these specific requirements during
transit to the laboratory for subsequent culture (24, 3 9 , 53,
54). PCR assays have also been developed (7, 9, 3 4 ) which
can detect as few as three C. fetus subsp. venerealis cells per ml
in experimentally infected raw and diluted bull semen (34).
Since Campylobacters have few unique biochemical features
(63), (more discriminating) techniques such as lipopolysacchari.de profiles and pulsed field gel electrophoresis
can assist in differentiating the venereal subspecies of C. fetus
from others (16, 7 5 ) .
Bulls are usually tested in quarantine by culture of preputial
samples on three occasions to ensure that they are free of
C. fetus before entering AI centres. Thereafter, their
disease-free status is confirmed by semi-annual testing.
Infected bulls may be treated by simultaneous preputial
infusion of an aqueous solution of DHS and subcutaneous
injections of the same antibiotic ( 7 8 ) . However,
streptomycin-resistant strains of C. fetus have been reported
(47), and as DHS has been withdrawn from some markets,
alternative treatments will be required in the future.
Vaccination is another possible approach which will not only
prevent infection in bulls ( 1 5 ) but is also claimed to be
curative, although failure to eliminate infection by vaccination
alone has been reported (46, 9 6 ) .
Various combinations of antibiotics have been used to control
C. fetus in liquid or frozen bovine semen ( 3 3 , 8 1 ) . One of
these, a combination of gentamycin, lincospectin and tylosin,
has been recommended ( 8 0 ) and adopted for commercial
application. However, it has been reported that C. fetus could
be re-isolated after processing and freezing of experimentally
inoculated semen in the presence of these three antibiotics
(32).
Trichomonosis
Trichomonosis is a venereal disease of cattle caused by the
protozoan parasite Tritrichomonas foetus. In the female, it is
characterised by infertility, early abortion and pyometra but in
the infected bull, a symptomless carrier state occurs with
T. foetus being found on the penis and preputial membranes.
This does not interfere with spermatogenic function or the
ability to copulate ( 3 1 ) . Trichomonosis occurs world-wide,
particularly among range cattle (44, 6 7 ) . A high herd
prevalence has been reported in areas of North America where
natural breeding is practised ( 1 3 , 7 3 ) . Control can be
achieved through a policy of testing breeding animals and the
widespread use of AI (87).
Disease risk
Although the parasite can survive in diluted semen and
through the freezing process, the probability of transmitting
infection through AI is not known. If transmitted to cows or
219
Rev. sci tech. Off. int Epiz., 16 (1)
heifers at breeding, the infection invades the vagina, uterus
and oviducts, causing embryonic death and infertility which
may last for several months (12).
Diagnosis and control
The testing of bulls entering AI should be mandatory, and
definitive diagnosis depends on the demonstration of the
living motile organisms in preputial washings or scrapings
(87). Since these organisms tend to be present only in small
numbers, a vigorous scraping of the preputial epithelium is
recommended. A diagnostic kit has been developed which
consists of a clear plastic pouch with two chambers of
selective medium. This is inoculated on-site with the sample
and is then used for both transport and culture (90). This kit
is an improvement compared to the traditional nutrient
medium for recovering T. foetus (14). The inoculated culture
media are examined microscopically for motile trichomonads
for up to seven to ten days (49). The probability of obtaining a
positive culture from a known positive bull has been
calculated to be between 8 1 . 6 % and 9 0 % based on three
successive weekly cultures (50, 8 2 ) .
Studies with an ELISA have shown it was sufficiently sensitive
to detect antibody in both seminal plasma and preputial
washings of bulls after vaccination and challenge with
T. foetus (19).
A specific DNA probe and PCR amplification system (45)
have also been used to detect ten T. foetus parasites in samples
containing bovine preputial smegma. Furthermore, a multiple
target PCR technique enabled T. foetus to be distinguished
from a variety of other protozoa. This might be a useful
adjunct to culture in the primary diagnosis of T. foetus
infection (73).
Bulls selected for entry into AI should preferably be from
disease-free herds and be tested in quarantine by the direct
microscopic and culture tests on three occasions to ensure
freedom from infection with T. foetus.
These health
certification requirements are similar to those for genital
campylobacteriosis. Continued freedom from infection
should then be confirmed by semi-annual tests. The J. foetus
protozoan is unaffected by antibiotics in semen extenders so if
an AI bull is found to be infected, the entire stock of frozen
semen or, at least, the semen collected from the date of the last
negative test should be destroyed (64). Information of value in
assessing the risk of T. foetus being present in imported semen
includes the country of origin of the semen, the history and
breed of the bull, and the testing programme applied by the
AI centre, with particular reference to the number of pre-entry
and annual tests for the organism.
categorisation of diseases according to the likelihood of
transmission through AI as shown in Table I. It should be
noted that the suggestions of the authors in regard to
Categories 1, 2 and 3 are based on current knowledge and
may change as new information becomes available. For some
diseases, there is ample evidence that transmission to the
female can occur through AI (Category 1, Table I), whereas
for others the available evidence suggests that the risk of
transmission through AI is low (Category 2, Table I). A third
category of disease agents includes those for which
information on transmission is limited, but based on the
reports which are available the authors propose that these
agents be subdivided into those likely to be transmitted in
semen (Category 3a, Table I) and those unlikely to be
transmitted (Category 3b, Table I).
To illustrate the concept, bluetongue virus (BTV) is listed in
Category 2 (Table I). This is because the presence of the virus
in bull semen tends to be associated with virus-infected blood
cells entering the male reproductive tract during the viraemic
phase of infection ( 6 9 ) . There is no evidence that bulb
develop persistent congenital infection or immunotolerance
to the virus, as is the case with BVDV. Thus, in areas free of
BTV, semen from seronegative bulls should pose a very low
risk, while the performance of tests to demonstrate the
absence of BTV in the blood of any bulls with circulating BTV
antibodies should provide a sufficient guarantee for the semen
of those bulls to be approved for export. In areas where the
disease is endemic, semen collected from bulls with or
without circulating antibodies, could also qualify for export
provided that blood tests confirmed that the bulls were free of
BTV at the time of collection. The schedule and frequency of
tests would be determined as part of any risk assessment
procedure.
Several excellent models are available for assessing the risk of
introducing disease into disease-free areas (58). Based on such
models, practical risk assessment protocols can be developed.
The quantitative assessment of risk of importation of disease
by bull semen should be based on several factors, including
the following:
- the country of origin and the incidence of the specific
diseases of concern to the importing country
- knowledge of epidemiology of these specific diseases
- standards of health certification for AI bulls and integrity
and technical competence with which certification is
performed
- standards of hygiene applied to collecting, processing and
storing semen
- antibiotic treatment of semen and extenders
Conclusions
- season of the year when semen is collected (relevant to
vector-bome diseases).
In addition to the six examples considered in detail above, a
wide variety of other disease agents may be excreted in bull
semen ( 1 , 3 1 , 3 3 , 4 3 , 6 9 ) . The authors propose a
Decisions on risk should be based on scientific knowledge of
the diseases of concern and on whether international
standards are applied for diagnosis and control.
220
Rev. sci tech. Off. int. Epiz., 16(1)
Table I
Risk of transmission of infectious bovine diseases through artificial insemination
Category
Diseases
1
Diseases with evidence that risk of transmission is moderate to high
Foot and mouth disease
Vesicular stomatitis
Rinderpest
Infectious bovine rhinotracheitis
Bovine virus diarrhoea
Bovine tuberculosis
Bovine genital campylobacteriosis
Bovine brucellosis
Trichomonosis
Mycoplasmosis
Haemophilus somnus
Ubiquitous bacteria (e.g. Pseudomonas aeruginosa, Escherichia coli)
Diseases with some evidence that risk of transmission is low
Bluetongue
Enzootic bovine leukosis
Bovine ephemeral fever
Akabane virus
Leptospirosis
Diseases with little or no information on risk of transmission
a ) Transmission of Category 3 diseases through artificial insemination likely
Epizootic haemorrhagic disease
Bovine immunodeficiency-like virus
Bovine paratuberculosis
Contagious bovine pleuropneumonia
b) Transmission of Category 3 diseases through artificial insemination unlikely
Lumpy skin disease
Rift Valley fever
Q fever
Rabies
Haemorrhagic septicaemia
Bovine malignant catarrhal fever
Bovine spongiform encephalopathy
Listeriosis
Anaplasmosls
Babesiosis
Chlamydia
Fungi, yeasts
2
3
+: Presence of disease agent in bull semen demonstrated
Presence of
disease agent
OIE Disease
List
+
A
A
A
B
NR
+
+
+
+
+
+
+
+
+
+
-
+
+
A
B
NR
-
+
+
B
B
B
B
B
+
+
+
+
-
+
A
A
B
NR
+
B
A
NR
NR
NR
NR
B
B
B
+
-
NR
NR
B
B
+
+
-
NR: Not reported
Consideration should also be given to the likely impact the
more virulent, strains of indigenous disease agents, which
disease would have on animal and human health in the event
may become established and cause major economic losses.
that the disease enters the country and becomes established. It
should be realised that there is a risk of introducing new,
•
221
Rev. sci tech. Off. int. Epiz., 16 (1)
Risques pour la santé animale associés
à l'insémination artificielle de bovins
M.D. Eaglesome & M.M. Garcia
Résumé
Deux des principaux objectifs de l'insémination artificielle des animaux
domestiques sont l'amélioration génétique permanente des cheptels et la
prévention ou l'élimination de maladies vénériennes. L'insémination artificielle
offre l'avantage de féconder autant de femelles et de produire autant de
descendants qu'en saillie, mais à partir d'un nombre limité de mâles. Toutefois,
l'insémination artificielle n'est pas exempte de risques ; elle peut, en effet, être à
l'origine de la dissémination de tares génétiques et propager des maladies
infectieuses à l'échelle nationale et internationale. Les auteurs examinent les
risques de transmission de six maladies spécifiques par la semence de taureau,
et décrivent les mesures appropriées pour prévenir ces risques.
Mots-clés
Bovins - Insémination artificielle - Maladies animales - Maladies génitales - Risque Semence.
Riesgos zoosanitarios asociados
a la inseminación artificial de bovino
M.D. Eaglesome & M.M. Garcia
Resumen
Alcanzar una continua mejora genética y prevenir o eliminar las enfermedades
venéreas son dos de los grandes objetivos de la inseminación artificial de
animales de granja. Comparada con la monta natural, la inseminación artificial
exige el concurso de menos machos para fecundar a un mismo número de
hembras y producir un mismo número de descendientes. Sin embargo, la
inseminación artificial no está exenta de riesgos, pues puede convertirse en vía
de diseminación de taras genéticas o en fuente de propagación de enfermedades
infecciosas a nivel tanto nacional como internacional. Los autores describen los
riesgos asociados a seis enfermedades específicas que se transmiten a través
del semen de toro, y presentan las medidas adecuadas para prevenir dichos
riesgos.
Palabras clave
Bovinos - Enfermedades genéticas - Enfermedades animales - Inseminación artificial Riesgo-Semen.
222
Rev. sci tech. Off. int. Epiz., 16(1)
References
1. Afshar A. & Eaglesome M.D. (1990). - Viruses associated
with bovine semen. Vet. Bull, 60 (2), 93-109.
2. Akhtar S., Riemann H.P., Thurmond M.C., Farver T.B. &
Franti C.E. (1990). - Multivariate logistic analysis of repeated
cross-sectional surveys of Campylobacter fetus in dairy cattle.
Prev. vet. Med., 10, 15-24.
3. Alt D.P. & Bolin C.A. (1996). - Preliminary evaluation of
antimicrobial agents for treatment of Leptospira interrogans
serovar pomona infection in hamsters and swine. Am. J. vet.
Res., 57 (1), 59-62.
4. Alton G.G.; Jones L.M. & Pietz D.E. (1975). - Laboratory
techniques in brucellosis, 2nd Ed. World Health
Organisation (WHO), Geneva, 163 pp.
5. Amatredjo A. & Campbell R.S.F.
leptospirosis. Vet. Bull, 43, 875-891.
(1975). -
Bovine
16. Brooks B.W., Garcia M.M., Robertson R.H. & Lior H. (1996).
- Electrophoretic and immunoblot analysis of Campylobacter
fetus lipopolysaccharides. Vet. Microbiol, 5 1 , 105-114.
17. Brunner D., Engels M., Schwyzer M. & Wyler R. (1988). - A
comparison of three techniques for detecting bovine
herpesvirus type 1 in naturally and experimentally
contaminated bovine semen. Zuchthygiene, 23, 1-9.
18. Bryan N.S. & Boley L.E. (1955). - Studies on leptospirosis in
domestic animals. IV. Survival of Leptospira pomona in bovine
semen extender. Mich. St. Univ. Vet., 16, 27-29, 55.
19. Campero C.M., Hirst R.G., Ladds P.W., Vaughan J.A., Emery
D.L. & Watson D.L. (1990). - Measurement of antibody in
serum and genital fluids of bulls by ELISA after vaccination
and challenge with Tritrichomonas foetus. Aust. vet.J., 67,
175-178.
6. Bartlett D.E. (1981). — Bull semen: specific microorganisms.
In FAO, disease control in semen and embryos. FAO Animal
Production and Health Paper No. 23, 29-48.
20. Campero C.M., Ladds P.W., Hoffmann D., Duffield B.,
Watson D. & Fordyce G. (1990). - Immunopathology of
experimental Brucella abortus strain 19 infection of the
genitalia of bulls. Vet. Immunol. Immunopathol, 24, 235-246.
7. Bastyns K., Chaelle S., VanDamme P., Goosens M. &
De Wächter R. (1994). - Species-specific detection of
Campylobacters important in veterinary medicine by PCR
amplification of 23S rDNA areas. Sys. appl. Microbiol, 17 (4),
563-568.
21. Caroff M., Bundle D.R., Perry M.B., Cherwonogrodzky J.W.
& Duncan J.R. (1984). - Antigenic S-type lipopolysaccharide
of Brucella abortus 1119-3. Infect. & Immunity, 4 6 , 384-388.
8. Bendixen H.C & Blom E. (1947). - The occurrence of
brucellosis in bulls and the importance of artificial
insemination. Maanedsskr. Dyrlaag, 59, 61-140.
9. Blom K., Patton C.M., Nicholson M.A.. & Swanminathan B.
(1995). - Identification of Campylobacter fetus by PCR-DNA
probe method J . clin. Microbiol, 33 (4), 1360-1362.
10. Bokhout B.A., Peterse D.J., Koger P.L. & Terpstra W.J.
(1989). - Preliminary serological survey for hardjo-positive
cows in the northern Netherlands. Tijdschr. Diergeneesk., 114,
123-130.
11. Bolin S.R. & Ridpath J.F. (1992). - Differences in virulence
between two noncytopathic bovine viral diarrhea viruses in
calves. Am. J. vet. Res., 53 (11), 2157-2163.
12. BonDurant R.H. (1985). - Diagnosis, treatment, and control
of bovine trichomoniasis. Compend. cont. Educ. pract. Vet, 7,
S179-S188.
13. BonDurant R.H., Anderson M.L., Blanchard P., Hird D.,
Danaye-Elmi C , Palmer C , Sischo W.M., Suther D.,
UtterbackW. & Weigler B.J. (1990). - Prevalence of
trichomoniasis among California beef herds. J. Am. vet. med.
Assoc., 196, 1590-1593.
14. Borchardt K.A., Norman B.N., Thomas M.W. &
Harmon W.M. (1992). - Evaluation of a new culture method
for diagnosing Tritrichomonas foerus. Vet. Med., 87, 104-112.
15. Bouters R., Keyser J. de, Vandeplassche M., Aert A. van, Brone
E. & Bonte P. (1973). - Vibrio fetus infection in bulls: curative
and preventive vaccination. Br. vet.]., 129, 52-57.
22. Cho H.J., Masri S.A., Deregt T.D., Yeo S.-G. & Thomas E.J.G.
(1991). - Sensitivity and specificity of an enzyme-linked
immunosorbent assay for the detection of bovine viral
diarrhea virus antibody in cattle. Can. J. vet. Res., 55, 56-59.
23. Clark B.L. (1971). - Review of bovine vibriosis. Aust. vet. J.,
47, 103-107.
24. Clark B.L. & Dufty J.H. (1978). - Isolation of Campylobacter
fetus from bulls. Aust. vet. J., 54, 262-263.
25. Cole J.R., Sulzer CR. & Pursell A.R. (1973). - Improved
microtechnique for the leptospiral microscopic agglutination
test. Appl. Microbiol, 25, 976-980.
26. Corbeil L.B., Schurig G.G.D., Bier P.J. & Winter A.J. (1975).
- Bovine venereal vibriosis: antigenic variation of the
bacterium during infection. Infect. & Immunity, 11, 240-244.
27. DaCosta M., Guillou J.-P., Garin-Bastuji B., Thiebaud M. &
Dubray G. (1996). - Specificity of six gene sequences for the
detection of the genus Brucella by DNA amplification. J. appl.
Bacteriol, 8 1 , 267-275.
28. Dennet D.P., Barasa J.O. &Johnson R.H. (1976). - Infectious
bovine rhinotracheitis virus: studies on the venereal carrier
state in range cattle. Res. vet. Sci., 20, 77-83.
29. Deregt D., Cho H.J. & Kozub G.C. (1993). - A comparative
evaluation of two sensitive serum neutralization tests for
bovine herpesvirus-1 antibodies. Can. J. vet. Res., 57 (1),
56-59.
30. Deregt D. & Loewen K G . (1995). - Bovine viral diarrhea
virus: biotypes and disease. Can. vet.J., 36, 371-378.
Rev. sci tech. Off. int. Epiz., 16 (1)
31. Eaglesome M.D. & Garcia M.M. (1992). - Microbial agents
associated with bovine genital tract infections and semen.
Part I. Brucella abortus, Leptospira, Campylobacter fetus and
Tritrichomonasfoetus. Vet. Bull, 62 (8), 743-775.
32. Eaglesome M.D. & Garcia M.M. (1992). - Survival of
Campylobacter fetus subsp. venerealis in antibiotic-treated
processed bovine semen. In Proc. 12th International
Conference on Animal Reproduction (ICAR), Vol. III. The
Hague, 23-27 August. ICAR Free Communication No. 457,
The Hague, 1542-1543.
33. Eaglesome M.D., Garcia M.M. & Stewart R.B. (1992). Microbial agents associated with bovine genital tract
infections. Part II. Haemophilus somnus, Mycoplasma spp. and
Ureaplasma spp., Chlamydia; pathogens and semen
contaminants; treatment of bull semen with antimicrobial
agents. Vet. Bull, 62 (9), 887-910.
34. Eaglesome M.D., Sampath M.I. & Garcia M.M. (1995). - A
detection assay for Campylobacter fetus in bovine semen by
restriction analysis of PCR amplified DNA. Vet Res. Comm.,
19, 253-263.
35. Ellis W.A. & Montgomery J.A. (1985). - Dihydrostreptomycin in treatment of bovine carriers of Leptospira interrogans
serovar hardjo. Res. vet. Sci., 39, 292-295.
223
44. Herr S., Ribeiro L.M.M., Claassen E. & Myburgh J.G. (1991).
- A reduction in the duration of infection with Tritrichomonas
foetus following vaccination in heifers and the failure to
demonstrate a curative effect in infected bulls. Onderstepoort J.
vet. Res., 58, 41-45.
45. Ho M.S.Y., Conrad P.A., Conrad P.J., LeFebvre R.B., Perez E.
& BonDurant R.H. (1994). - Detection of bovine
trichomoniasis with a specific DNA probe and PCR
amplification system. J. clin. Microbiol, 3 2 (1), 98-104.
46. Hum S., Brunner J. & Gardiner B. (1993). - Failure of
therapeutic vaccination of a bull infected with Campylobacter
fetus. Aust. vet.J., 70 (10), 386-387. .
47. Jones R.L., Davis M.A. & Vonbyem H. (1985). - Cultural
procedures for the isolation of Campylobacter fetus subspecies
venerealis from preputial secretions and occurrence of
antimicrobial resistance. In Proc. Annual Meeting of the
American
Association
of
Veterinary
Laboratory
Diagnosticians, 27-29 October. American Association of
Veterinary Laboratory Diagnosticians, Brookings, South
Dakota, 28, 225-238.
48. Kiktenko V.S., Balashov N.G. & Rodina V.N. (1976). Leptospirosis infection through insemination of animals.
J. Hyg. Epidemiol. Microbiol. and Immunol, 20, 207-213.
36. Ellis W.A., Cassells J.A. & Doyle J . (1986). - Genital
leptospirosis in bulls. Vet. Rec., 118, 333.
49. Kimsey P.B. (1986). - Bovine trichomoniasis. In Current
therapy in theriogenology, Part II (D.A. Morrow, ed.).
W.B. Saunders & Co., Philadelphia, 275-279.
37. Fekete A., Bantle J.A. & Hailing S.M. (1992). - Detection of
Brucella by polymerase chain reaction in bovine fetal and
maternal tissues. J. vet. Diagn. Invest., 4, 79-83.
50. Kimsey P.B., Darien B.J., Kendrick J.W. & Franti C.E. (1980).
- Bovine trichomoniasis: diagnosis and treatment. J. Am. vet.
med. Assoc., 177, 616-619.
38. Gall D. & Nielsen K. (1994). - Improvements to the
competitive ELISA for detection of antibodies to Brucella
abortus in cattle sera. J. Immunoassay, 15 (3), 277-291.
51. Kirkland P.D., Richards S.G., Rothwell J.T. & Stanley D.F.
(1991). - Replication of bovine viral diarrhoea virus in the
bovine reproductive tract and excretion of virus in semen
during acute and chronic infections. Vet. Rec., 128, 587-590.
39. Garcia M.M., Stewart R.B. & Ruckerbauer G.M. (1984). Quantitative evaluation of a transport enrichment medium
for Campylobacter fetus. Vet. Rec., 115, 434-436.
52. Kommisrud E., Vatn T., Lang-Ree J.R. & Loken T. (1996). Bovine virus diarrhoea virus in semen from acutely infected
bulls. Acta. vet. Scand., 37, 41-47.
40. Garcia
M.M.,
Lutze-Wallace
C.L.,
Denes A.S.,
Eaglesome M.D., Holst E. & Blaser M.J. (1995). - Protein
shift and antigenic variation in the S-layer of Campylobacter
fetus subsp. venerealis during bovine infection accompanied
by genomic rearrangement of sap A homologs. J. Bacterial.,
177 (8), 1976-1980.
53. Lander K.P. (1990). - The development of a transport and
enrichment medium for Campylobacter fetus. Br. vet. J., 146,
327-333.
41. Gerritsen M.J., Olyhoek T., Smits M.A. & Bokhout B.A.
(1991). - Sample preparation method for polymerase chain
reaction-based semiquantitative detection of Leptospira
interrogans serovar hardjo subtype hardjobovis in bovine urine.
J. clin. Microbiol, 2 9 , 2805-2808.
55. McGowan M.R., Kirkland P.D., Richards S.G. & Littlejohns
I.R. (1993). - Increased reproductive losses in cattle infected
with bovine pestivirus around the time of insemination. Vet.
Rec., 133, 39-43.
42. Godfroid J . , Vanopdenbosch E., Wellemans G. & Letesson J.J.
(1994). - Bovine herpesvirus 1 diagnosis based on an in vitro
antigenic-specific IFN-y production. In Proc. Third Congress
of the European Society of Veterinary Virology. Interlaken,
Switzerland, 2, 11.
43. Hare W.C.D. (1985). - Diseases transmissible by semen and
embryo transfer techniques. Technical Series No. 4. Office
International des Epizooties, Paris, 117 pp.
54. Lander K.P. (1990). - The application of a transport and
enrichment medium to the diagnosis of Campylobacter fetus
infections in bulls. Br. vet.J., 146, 334-340.
56. Meyling A. & Jensen A.M. (1988). - Transmission of bovine
virus diarrhoea virus (BVDV) by artificial insemination (AI)
with semen from a persistently-infected bull. Vet. Microbiol.,
17, 97-105.
57. Monke D.R. & Howard T.H. (1992). - IBR research update
and commentary. In Proc. 14th Technical Conference on
artificial insemination and reproduction, 24-25 April.
National Association of Animal Breeders, Milwaukee,
Wisconsin, 14, 26-29.
224
Rev. sCi tech. Off. int. Epiz., 16 (1)
58. Morley R.S. (ed.) (1993). - Risk analysis, animal health and
trade. Rev. sCi. tech. Off. int. Epiz., 12 (4), 448 pp.
59. Nettleton P.F. & Entrican G. (1995).
pestiviruses. Br. vet.J., 151, 615-642.
-
Ruminant
60. Nicoletti P. (1986). - Effects of brucellosis on bovine
reproductive efficiency. In Current therapy in theriogenology,
Part II (D.A. Morrow, ed.). W.B. Saunders & Co.,
Philadelphia, 271-274.
61. Nielsen K., Cherwonogrodzky J.W., Duncan J.R. & Bundle
D.R (1989). - Enzyme-linked immunosorbent assay for
differentiation of the antibody response of cattle naturally
infected with Brucella abortus or vaccinated with strain 19.
Am.J, vet. Res., 50, 5-9.
62. Office International des Epizooties (OIE) (1992, updated
1996). - International Animal Health Code, 6th Ed. OIE,
Paris, 550 pp.
63. On S.L.W. & Holmes B. (1991). - Reproducibility of
tolerance tests that are useful in the identification of
Campylobacter. J. clin. Microbiol, 29, 1785-1788.
64. Parez M. (1984). - The most important genital diseases of
cattle (control, treatment and the hygiene of semen
collection), In Proc. 11th Conference of the OIE Regional
Commission for Europe, Vienna, 25-28 September. OIE,
Paris, 175-203.
65. Pastoret P.-P., Babiuk L.A., Misra V. & Briebel P. (1984). Reactivation of temperature sensitive and non-temperature
sensitive infectious bovine rhinotracheitis vaccine virus with
dexamethasome. Infect. & Immunity, 29, 493-497.
66. Paton D.J., Goodey R., Brockman S. & Wood L. (1989). Evaluation of the quality and virological status of semen from
bulls acutely infected with BVDV. Vet. Rec.., 124, 63-64.
67. Pefanis S.M., Herr S., Venter C.G., Kruger L.P.,
Queiroga C.C. & Amaral L. (1988). - Trichomoniasis and
campylobacteriosis in bulls in the Republic of Transkei.
J. S. Afr. vet. Assoc., 59,139-140.
73. Riley D.E., Wagner B., Polley L. & Krieger J.N. (1995).
PCR-based study of conserved and variable DNA sequences
of Tritrichomonas foetus isolates from Saskatchewan, Canada.
J. clin. Microbiol, 33 (5), 1308-1313.
74. Rodina V.N. & Balashov N.G. (1971). - Leptospiral infection
of animals transmitted through insemination. In Proc. 19th
World Veterinary Congress, Mexico City, Vol. 2. World
Veterinary Congress, Mexico City, 708-709.
75. Salama S.M., Garcia M.M. & Taylor D.E. (1992). Differentiation of the subspecies of Campylobacter fetus by
genome sizing. Int. J. Syst. Bact., 42, 446-450.
76. Schultz R.D., Adams L.S., Letchworth G., Sheffy B.E.,
Manning T. & Bean B. (1982). - A method to test large
numbers of bovine semen samples for viral contamination
and results of a study using this method. Theriogenology, 17,
115-123.
77. Schurig G., Boyle S. & Sriranganathan N.S. (1996). - Brucella
abortus vaccine strain RB51: a brief review. Arch. Med. Vet,
X X V I I (special issue), 19-22.
78. Seger C.L., Lank R.B. & Levy H.E. (1966). - Dihydrostreptomycin for treatment of genital vibriosis in the bull.
J. Am. vet. med. Assoc., 149, 1634-1639.
79. Shannon A.D., Mackintosh S.G. & Kirkland P.D. (1992). Identification of pestivirus carrier calves by an antigencapture ELISA. Aust. vet.J., 70 (2), 74-76.
80. Shin S.J., Lein D.H., Patten V.H. & Runnke H.L. (1988). - A
new antibiotic combination for frozen bovine semen. 1.
Control of mycoplasmas, Ureaplasmas, Campylobacter fetus
subsp. venerealis and Haemophilus somnus. Theriogenology, 29
(3), 577-591.
81. Shisong C , Redwood D.W. & Ellis B. (1990). - Control of
Campylobacter fetus in artificially contaminated bovine semen
by incubation with antibiotics before freezing. Br. vet. J., 146,
68-74.
82. Skirrow S., BonDurant R., Farley J . & Correa J . (1985). Efficacy of ipronidazole against trichomoniasis in beef bulls.
J. Am. vet. med. Assoc., 187, 405-407.
68. Pfeffer M., Wiedmann M. & Batt C.A. (1995). - Applications
of DNA amplification techniques in veterinary diagnosis. Vet.
Res. Comm., 19, 375-407.
83. Sleight S.D. (1965). - The role of penicillin and streptomycin
in the prevention of transmission of bovine leptospirosis by
artificial insemination. Am.J. vet. Res., 26, 365-368.
69. Phillpot M. (1993). - The dangers of disease transmission by
artificial insemination and embryo transfer. Br. vet. J., 149,
339-369.
84. Sleight S.D., Atollah O.A. & Steinbauer D.J. (1964). Experimental leptospiral pomona infection in bulls. Am. J. vet.
Res., 25, 1663-1668.
70. Plant J.W., Claxton P.D., Jakovlyevic D. & De Saram W.
(1976). - Brucella abortus infection in the bull. Aust. vet. J., 52,
17-20.
85. Smith C.R., Ketterer P.J., McGowan M.R. & Corney B.G.
(1994). - A review of laboratory techniques and their use in
the diagnosis of Leptospira interrogans serovar hardjo infection
in cattle. Aust. vet.J., 71 (9), 290-294.
71. Radostits O.M. & Litdejohns I.R. (1988). - New concepts in
the pathogenesis, diagnosis and control of diseases caused by
the bovine viral diarrhea virus. Can. vet.J., 29, 513-525.
72. Ramadass P., Jarvis B.D.W., Corner R.J., Penny D. & Marshall
R.B. (1992). - Genetic characterization of pathogenic
Leptospira species by DNA hybridisation. Int. J. Syst. Bact., 42
(2), 215-219.
86. Straub O.C (1990). - Infectious bovine rhinotracheitis. In
Virus infections of ruminants (Z. Dinter & B. Morein, eds).
Elsevier Science Publishers, Amsterdam, 71-108.
87. Taylor M.A., Marshall R.N. & Stack M. (1994). Morphological differentiation of Tritrichomonas foetus from
other protozoa of the bovine reproductive tract. Br. vet. J.,
150, 73-80.
Rev. sci tech. Off. int. Epiz., 16(1)
88. Terpstra W.J. (1989). - Enzymatic detection systems for
leptospiral antibodies. antigen, and nucleic acids, In Proc.
Canadian Society of Microbiologists Symposium on
Leptospires, Vol. 1 (Part 3). Canadian Society of
Microbiologists, Laval, Quebec, 14 June, 1-24.
89. Thiermann A.B. & Ellis W.A. (1986). - Identification of
leptospires of veterinary importance by restriction
endonuclease analysis. In The present state of leptospirosis
diagnosis and control (W.A. Ellis & W.A. Little, eds).
Martinus Nijhoff Publishers, Dordrecht, 91-104.
225
campylobacteriosis (vibriosis): vaccination of experimentally
infected bulls. Am. J. vet. Res., 4 4 (8), 1553-1557.
97. Vilcek S., Nettieton P.F., Herring J.A. & Herring A.J. (1994).
- Rapid detection of bovine herpes virus 1 (BHV-1) using the
polymerase chain reaction. Vet. Microbiol, 42, 56-64.
98. Villar J.A. & Spina E.M. (1982). - Campilobacteriosis
(vibriosis) bovina. Una recopilación de datos sobre su
incidencia en el periodo 1966-1981. Gac. Vet, 4 4 , 647-658.
90. Thomas M.W., Harmon W.M. & White C. (1990). - An
improved method for the detection of Tritrichomonas foetus
infection by culture in bulls. Agri-Practice, 11, 13-17.
99. Virakul P., Fahning M.L., Joo H.S. & Zemjanis R. (1988). Fertility of cows challenged with bovine viral diarrhea virus
during an outbreak of spontaneous infection with a
noncytopathic strain. Theriogenology, 29 (2), 441-449.
91. Trueba G.A., Bolin C.A. & Thoen C O . (1990). - Evaluation
of an enzyme immunoassay for diagnosis of bovine
leptospirosis caused by Leptospira interrogans serovar hardjo
type hardjo-bovis. J. vet. Diagn. Invest., 2, 323-329.
100. Weiblen R., Kreutz L.C., Canabarro T.F., Schuch L.F. &
Rebelatto M.C (1992). - Isolation of bovine herpesvirus 1
from preputial swabs and semen of bulls with
balanoposthitis. J. vet. Diagn. Invest., 4, 341-343.
92. Truyen U., Parrish C.R., Harder T.C. & Kaaden O.-R. (1995).
- There is nothing permanent except change. The emergence
of new virus diseases. Vet. Microbiol, 43, 103-122.
101. Winter A.J. (1982). - Microbial immunity in the
reproductive tract. J. Am. vet. med. Assoc., 181 (10),
1969-1073.
93. Van Aert A., Brioen P., Dekeyser P., Uytterhaegen L.,
Sijens R.J. & Boeye A. (1984). - A comparative study of
ELISA and other methods for the detection of Brucella
antibodies in bovine sera. Vet. Microbiol, 10, 3-21.
102. World Health Organisation (WHO) (1967). - Current
problems in leptospirosis research. Technical Report Series
No. 380. WHO, Geneva, 32 pp.
94. Van der Oirschot J.T. (1995). - Bovine herpes virus 1 in
semen of bulls and the risk of transmission: a brief review.
Vet. Q., 17 (1), 29-33.
95. Van der Oirschot J.T., Straver P.J., van Lieshout J.A.H.,
Quak J . , Westenbrink F. & van Exsel A.C.A. (1993). A subclinical infection of bulls with bovine herpesvirus type 1
at an artificial insemination centre. Vet. Rec., 132, 32-35.
96. Vasquez L.A., Ball L., Bennett B.W., Rupp G.P., Ellis R.,
Olson J.D. & Huffman M.H. (1983). - Bovine genital
103. Xia J.Q., Lofstedt R.M., Yason C.V. & Kibenge F.S.B. (1995).
- Detection of bovine herpes virus-1 in the semen of
experimentally infected bulls by dot-blot hybridisation,
polymerase chain reaction and virus isolation. Res. vet. Sci.,
59, 183-185.
104. Xia J.Q., Yason C.V. & Kibenge F.S.B. (1995). - Comparison
of dot-blot hybridisation, polymerase chain reaction and
virus isolation for detection of bovine herpes virus-1
(BHV-1) in artificially infected bovine semen. Can. J. vet. Res.,
59, 102-109.